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VaccineHepatitis C virus (HCV) puriﬁcation by ultracentrifugation is difﬁcult because of the low and heterogeneous
density of native and cultured viruses. It was recently shown that inserting ﬂag tag into envelope protein 2
(E2) of HCV permitted virus puriﬁcation by afﬁnity chromatography. However, ﬂag-tagged viruses had
drastically altered properties, and puriﬁcation yield was low. In this study, we found that insertion of ﬂag tag
at the N-terminus of E2 in HCV recombinant J6/JFH1 did not affect viability in Huh7.5 cells, and that ﬂag-
tagged virus had physiochemical properties similar to the original virus. Flag-tagged virus was susceptible to
ﬂag-speciﬁc antibody neutralization, and infected cells could be immuno-stained by anti-ﬂag antibodies.
Using afﬁnity chromatography with anti-ﬂag resin we repeatedly obtained ~30% recovery of infectious
particles. The full viability and unaltered physiochemical properties of ﬂag-tagged HCV is an important
improvement for utilizing these viruses for imaging, virion composition analysis and possibly vaccine
development.protein 2; ORF, open reading
rvariable region 1; FFUs, focus
iseases, Copenhagen University
, Denmark. Fax: +45 36474979.
ih.gov (J. Bukh).
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Approximately 180 million people worldwide are persistently
infected with hepatitis C virus (HCV) and are therefore at an increased
risk of developing liver-related complications, such as liver cirrhosis
and hepatocellular carcinoma (Alter and Seeff, 2000). HCV is a
positive single-strand RNA virus belonging to the Flaviviridae family,
and its genome consists of highly structured 5′ and 3′ untranslated
regions at opposite ends of a single open reading frame (ORF), which
encodes the structural genes Core, envelope protein 1 and 2 (E1 and
E2) followed by p7 and the nonstructural genes NS2, NS3, NS4A, NS4B,
NS5A and NS5B (Gottwein and Bukh, 2008).
HCV is believed to associate with very low density lipoprotein
(VLDL) during assembly and release. This association is substantiated
by the facts that HCV morphogenesis and release is affected by
inhibition of the hepatocyte VLDL machinery (Syed et al., 2010) and
by observations that native HCV virions from serum of infected
patients are co-immunoprecipitated by apoB-speciﬁc antibodies andare found to have densities overlapping with that of LDL (Thomssen
et al., 1992).
The discovery of the HCV genotype 2a isolate, JFH1, whichwas able
to infect Huh7 hepatoma cells and derived cell lines (Wakita et al.,
2005) opened up new venues for drug screening and for probing the
virus life cycle. We based the current study on the related HCV
genotype 2a intragenotypic recombinant virus, J6/JFH1, known to be
cell culture infectious and genetically stable (Gottwein et al., 2007;
Lindenbach et al., 2005). In order to effectively utilize these viruses for
detailed studies of virus particles, puriﬁcation from cell culture
medium components is required. However, the low and heteroge-
neous density of native aswell as cell culture derivedHCV (Andre et al.,
2002; Nielsen et al., 2006) makes the classical ultracentrifugation
approaches to virus puriﬁcation from cell culture unfeasible. This
potentially hinders accurate investigation of virion composition, as
well as the efforts to develop an inactivated whole virus HCV vaccine.
Earlier this year it was reported that it was possible to insert ﬂag
tag near the N-terminus of E2 (replacing a part of hypervariable
region 1 (HVR1)) of a genotype 2a JFH1-based HCV recombinant
(Takahashi et al., 2010). However, the ﬂag-tagged virus was greatly
attenuated. Infectivity could be partly rescued by an envelope
mutation, but the virus had altered physiochemical properties with
a density above 1.10 g/ml. The authors showed that it was possible to
perform ﬂag tag based afﬁnity chromatography puriﬁcation of
infectious particles using ﬂag peptide competition for elution. In a
149Rapid Communicationparallel and independent approachwe attempted to insert the ﬂag tag
at the very N-terminus of E2 with a short linker, and found no
apparent effect on virus infectivity and physiochemical properties (i.e.
virus density was unaltered at around 1.01 to 1.10 g/ml). Further-
more, infected cells could be speciﬁcally immuno-stained for ﬂag-E2
of HCV, and viruses released from cultured cells were efﬁciently
neutralized by anti-ﬂag antibodies. Finally we were able to recover
~30% of infectious HCV particles while eluting virus at high purity
using the inexpensive EDTA as a chelating agent. These advances add
greatly to the usefulness of ﬂag-tagged viruses for virus puriﬁcation
and virion composition studies, and in particular it should advance the
study of the HCV E2 protein.
Results
HCV recombinant J6/JFH1 tolerates insertion of 14 amino acids at the
N-terminus of E2 in vitro
We initially attempted to insert EGFP at the N-terminus of E2 of
the HCV recombinant J6/JFH1. Following HCV RNA transfection of
Huh7.5 cells with EGFP-tagged J6/JFH1 we observed bright HCV
staining of a subpopulation of cells by NS5A-speciﬁc immuno-
stainings in addition to a green ﬂuorescent signal from EGFP, which
was not observed in a control transfection using un-modiﬁed J6/JFH1
(not shown). However, the virus was severely attenuated and virus
spread did not occur until day 10 reaching peak infection at day 17.
Viral spread was concurrent with the loss of the EGFP signal and full
ORF sequencing of HCV RNA extracted from virions recovered from
cell culture supernatants revealed that the EGFP protein had been
deleted except for a 14 amino acid sequence (MVSKGEELFKGSSG) at
the N-terminus of E2.
Insertion of ﬂag tag and a linker at the N-terminus of E2 of HCV
recombinant J6/JFH1 had no apparent impact on virus viability or
physiochemical properties in Huh7.5 cells
Based on the observation that the J6/JFH1 recombinant tolerated a
14 aa insertion at the E2 N-terminus, we decided to attempt the
insertion of a sequence encoding 13 aa, consisting of ﬂag tag
(DYKDDDDK) with a short linker (LPGTG), at the N-terminus of E2
of this HCV recombinant. Upon HCV RNA transfection of Huh7.5 cells
with J6/JFH1 and the ﬂag-tagged J6/JFH1ﬂag, we found that both
recombinants replicated with similar viral spread, as measured by
NS5A-speciﬁc immuno-stainings of cells collected days 1, 3, 6 and
8 post-transfection (Fig. 1). Also, HCV infectivity titrations of
supernatant collected at days 3, 6 and 8 post-transfection revealed
similar peak infectious titers (Fig. 1). The ﬂag-tagged virus displayedFig. 1. The HCV recombinant J6/JFH1 virus with a ﬂag tag at the N-terminus of structural
protein E2 (J6/JFH1ﬂag) was fully infectious. HCV RNA transfection of Huh7.5 cells
revealed that J6/JFH1 and J6/JFH1ﬂag displayed similar spread in culture asmonitored by
immuno-stainings for HCV protein NS5A (closed symbols), as well as similar HCV
infectivity titers in culture supernatants collected at days 3, 6 and 8 post-transfection
(open symbols). Infectivity titration was done in an FFU assay, shown as mean of three
replicates with SD (lower cut-off: 100 FFUs/ml).HCV infectivity titers up to 4.5 log10 focus forming units (FFUs)/ml in
subsequent viral passages (not shown). Full ORF sequencing of HCV
RNA extracted from virions recovered from cell culture supernatants
from 1st and 2nd passage cultures of J6/JFH1ﬂag showed that the
tagged genome was genetically stable with the ﬂag tag and linker
maintained and no additional changes in the J6/JFH1 consensus
sequence. We therefore concluded that J6/JFH1ﬂag was fully viable
in vitro.
We next examined whether the physiochemical virus properties
had been altered by ﬂag tag insertion by performing equilibrium
buoyant density centrifugation comparing J6/JFH1 virus with J6/
JFH1ﬂag. The gradient was formed using iodixanol to best preserve
virus–lipid associations (Nielsen et al., 2006). Analysis of fractions
with densities ranging from 1.0 to at least 1.24 g/ml revealed that
infectious particles for both viruses had densities between ~1.01 and
1.10 g/ml (Fig. 2A), and signiﬁcant HCV RNA titers were found in
fractions between ~1.0 and 1.12 g/ml (Fig. 2B). Although we did
observe an overall decrease in speciﬁc infectivity of the fractions for
J6/JFH1ﬂag as compared to J6/JFH1, the HCV RNA and infectious
particle distributions were similar. This observed difference in speciﬁc
infectivity could potentially stem from the fact that the J6/JFH1 stock
used in this particular experiment was one characterized previously
(Gottwein et al., 2009), thusmerely reﬂecting variation between virusFig. 2. J6/JFH1ﬂag had similar physiochemical properties as the unmodiﬁed J6/JFH1.
Equilibrium gradient density centrifugation was performed using J6/JFH1 from a
previously generated high titer virus stock (Gottwein et al., 2009) and a 2nd passage of
the J6/JFH1ﬂag virus. The procedure was done using iodixanol as described in Materials
and methods. After centrifugation, ~700 μl gradient fractions were harvested from the
bottom and 500 μl were weighed to calculate fraction densities. A. HCV infectivity
titration (shown with SD; lower cut-off: 500 FFUs/ml) and B. HCV RNA titration (lower
cut-off: 5000 IU/ml) was performed for each fraction.
Fig. 4. J6/JFH1ﬂag viruses were highly susceptible to neutralization by ﬂag-speciﬁc
antibodies. J6/JFH1 and J6/JFH1ﬂag viruses were incubated for 1 h at 37 °C with different
concentrations of a monoclonal antibody (clone M2, Sigma) directed against the ﬂag
motif. The virus/antibody mixture was then incubated with the cells for 3 h prior to
wash and addition of fresh medium. Forty-eight hours after infection the plates were
ﬁxed and stained for the NS5A protein. FFUs were scored automatically using
ImmunoSpot Series 5 UV Analyzer (Gottwein et al., 2010) as described in Materials
and methods. Neutralization data is shown as mean of four replicates with SEM related
to mean of six replicates of virus only.
150 Rapid Communicationpreparationsmade at different time points. Overall, we concluded that
the insertion of an E2 N-terminal ﬂag tag into HCV recombinant J6/
JFH1 had no major impact on virus infectivity and composition.
J6/JFH1ﬂag infected Huh7.5 cells were speciﬁcally stained using
ﬂag-speciﬁc antibodies
We stained cultured cells that were either infected with ﬁrst
passage J6/JFH1 or J6/JFH1ﬂag using non-infected cells as a control.
Using virus collected from day 8 transfection supernatants from the
experiment shown in Fig. 1 we inoculated 6-well plates as described
in Materials and methods at a multiplicity of infection (MOI) of
0.01 FFUs/cell. Cells were ﬁxed on day 3 post-infection, and immuno-
stained with primary antibodies against HCV NS5A and the ﬂag motif.
As expected we observed speciﬁc staining of NS5A for both J6/JFH1
and J6/JFH1ﬂag (Fig. 3), whereas staining of ﬂag-tagged E2 only
occurred for the J6/JFH1ﬂag infected cells (Fig. 3).
J6/JFH1ﬂag virions were speciﬁcally neutralized by ﬂag-tag antibodies
The HVR1 of the HCV E2 protein, located downstream of the ﬂag
insertion in J6/JFH1ﬂag, is believed to be exposed at the surface of the
HCV particle. We therefore tested whether binding of ﬂag-speciﬁc
antibodies to the ﬂag epitope would result in neutralization of the
virus by incubating J6/JFH1 and J6/JFH1ﬂag with ﬂag-speciﬁc anti-
bodies for 1 h prior to infection of Huh7.5 cells (see Materials and
methods). Interestingly, we observed a dose-dependent neutraliza-
tion of the ﬂag-tagged virus at an efﬁciency of ~90% at the highestFig. 3. Huh7.5 cells infected with J6/JFH1ﬂag expressing ﬂag-tagged E2 exhibit ﬂag-speciﬁc im
cell. Stainings were performed at day 3 post-infection; the staining procedure was carriedantibody doses (Fig. 4). In contrast, the infection with unmodiﬁed J6/
JFH1 recombinant was unaffected (Fig. 4), showing that the
neutralization was a speciﬁc effect of the ﬂag tag insertion in E2.
We concluded that the ﬂag tag was available for virion neutralization
by ﬂag-speciﬁc antibodiesmost likely through steric interferencewith
envelope motifs of importance for HCV entry.muno-staining. Cells were infected with J6/JFH1 and J6/JFH1ﬂag at an MOI of 0.01 FFUs/
out as described in Materials and methods.
151Rapid CommunicationOne-step puriﬁcation of ﬂag-tagged HCV by anti-ﬂag speciﬁc afﬁnity
chromatography of cell culture supernatant
We evaluated the efﬁciency of two commercially available ﬂag
antibody based afﬁnity gels for column-based chromatography of
infectious J6/JFH1ﬂag virus particles. Resin M1 is conjugated to an
antibody (clone M1, Sigma), which binds the ﬂag motif in a calcium
dependent manner. Resin M2 is conjugated to an antibody (clone M2,
Sigma), which binds the ﬂag motif in a calcium independent manner.
Therefore elution of particles bound to resinM1 should be attainable by
complexing the calcium in the binding buffer using EDTA, whereas
elution of particles bound to resin M2 requires the more expensive ﬂag
peptide competition. Using 2nd passage J6/JFH1ﬂag virus, which we had
veriﬁed to bewithout changes in theORF consensus sequence, retainingFig. 5. J6/JFH1ﬂag viruses could be puriﬁed by afﬁnity column chromatography with either o
JFH1ﬂag supernatant was used in gravity ﬂow afﬁnity column chromatography puriﬁcation
~500 μl of resin) was added to empty PD10 columns and prepared as described in Materials a
columns and passed through the resin twice. The columns were then washed twice in 5 ml
under mild conditions in appropriate buffer (see Materials andmethods). The eluting compo
fractions of 1.8 ml acidic buffer (pH 3.5) were used for a stronger elution for both resins.
Infectivity titration was done in an FFU assay, shown as mean of three replicates with SD (l
calculated by multiplying fraction titers with volumes. The % of FFUs compared to the input wthe ﬂag and linker sequence at the N-terminus of E2, we performed
puriﬁcation by afﬁnity column chromatography as described in
Materials and methods, and analyzed the puriﬁcation fractions pre-
column,ﬂow-through,wash 1,wash 2 and elution fractions 1–6 forHCV
infectivity by FFU assays (Fig. 5A–B). Theﬂag-tagged 2a viruses could be
puriﬁed by using either the M1 or M2 resin. However, recovery of
infectious HCV was higher using the M1 resin (30% of input for M1
compared to 15% for M2, Fig. 5C–D), and coupled with the relative low
cost of EDTA(M1) for elution itwould seemthatM1 is the resinof choice
for large scale puriﬁcation. AnalyzingHCVRNAas described inMaterials
and methods of the collected puriﬁcation fractions we veriﬁed that a
largeproportion ofHCVparticleswere not boundby either resin. Finally,
we attempted acidic elution, which is thought to be more effective, but
failed to recover signiﬁcant amounts of HCV infectivity or HCV RNA.f two available anti-ﬂag resins (M1 and M2). Thirty-three milliliters of 2nd passage J6/
with either M1 or M2 anti-ﬂag speciﬁc resins. Resin slurry (1000 μl; corresponding to
nd methods. The virus was concentrated into 4.3 ml (M1) or 4.1 ml (M2) using amicon
of appropriate buffer (see Materials and methods) and eluted into 3 fractions of 1.8 ml
nent was either 5 mM EDTA (M1) or 150 μg/ml of 3×ﬂag peptide (M2). Subsequently, 3
(A–B) The fractions were HCV infectivity titrated and HCV RNA titrated (not shown).
ower cut-off: 500 FFUs/ml). Star, titer below cut-off. (C–D) Total FFUs in fractions was
as calculated by normalizing to the amount of FFUs in the input fractions (pre-column).
152 Rapid CommunicationSince we attained high binding to resin M2 and the resin
manufacturer (Sigma) states that the two resin have identical binding
capacities for ﬂag-tagged protein it does not appear that the total resin
binding capacity was the explanation for decreased binding of virus to
the M1 resin. To investigate if puriﬁed HCV particles represented a
virus population with a greater surface expression of the ﬂagmotif we
incubated J6/JFH1, non-puriﬁed J6/JFH1ﬂag and puriﬁed J6/JFH1ﬂag
(puriﬁed virus from Fig. 5, M1 puriﬁcation, fraction E1) with ﬂag
antibodies as described above. We observed efﬁcient neutralization of
ﬂag-tagged viruses with no difference in susceptibility to ﬂag
antibodies between non-puriﬁed and puriﬁed J6/JFH1ﬂag, and we
did not observe neutralization of unmodiﬁed J6/JFH1 (Fig. 6).
Since availability of the ﬂag tag did not seem to be the determining
factor in HCV binding to the resin we attempted to boost binding by
increasing virus/resin incubation time. Initially we attempted a full
batch puriﬁcation method (no column) in which ﬂag-tagged virus
was incubated with ﬂag antibody-coated beads that were then spun
down. Then the beads were washed and spun down two times, and
ﬁnally bound viruses were eluted by incubating the beads in elution
buffer and spinning down three times. The yield was below 1% in two
separate attempts and we therefore abandoned this approach. In a
new puriﬁcation using resin M1 we pre-incubated ﬂag-tagged HCV
particles with the resin for 1 h at RT prior to allowing the resin to
settle in the column. The remaining part of the puriﬁcation process
from washing to elution was performed as described in Materials and
methods.We did observe increased binding (Fig. 7), but regardless we
were unable to achieve infectious HCV recovery higher than ~30%. To
analyze protein content of the puriﬁcation fractions we performed
protein measurements using a modiﬁed Bradford protocol with a
sensitivity of ~8 ng/μl (Table 1, only input and elution fraction 1
shown). The protein content of the puriﬁed fractions was below the
detection limit meaning that we had achieved at least a 1200-fold
increase in purity when comparing FFUs to total protein (Table 1). The
speciﬁc infectivity had been increased ~4-fold by the puriﬁcation
process (Table 1), which resembles a previous observation (Takahashi
et al., 2010). We next performed silver staining with a veriﬁed
sensitivity of ~1 ng/protein band of the puriﬁcation fractions. We
observed only faint protein contamination of the elution fractions at a
molecular weight corresponding to bovine serum albumin when
loading 40 μl of the elution fractions (Fig. 8). This indicated that thisFig. 6. Neutralization of ﬂag-tagged J6/JFH1 viruses before and after puriﬁcation.
Viruses were neutralized by incubation for 1 h at 37 °C with different concentrations of
monoclonal antibody (clone M2) directed against the ﬂag motif. The virus/antibody
mixture was then incubated with the cells for 3 h prior to wash and addition of fresh
medium. Forty-eight hours after infection the plates were ﬁxed and stained for NS5A
protein. FFUs were scored automatically using ImmunoSpot Series 5 UV Analyzer
(Gottwein et al., 2010) as described in Materials and methods, except for the puriﬁed
virus, which was scored manually. Neutralization data is shown as mean of four
replicates with SEM related to mean of six replicates of virus only.
Fig. 7. Batch incubation puriﬁcation increased virus binding of ﬂag-tagged HCV to the
M1 resin, but did not increase infectious particle content of elution fractions. Thirty-
four milliliters of 2nd passage supernatant was used in gravity ﬂow afﬁnity column
chromatography puriﬁcation with M1 anti-ﬂag speciﬁc resin. Resin slurry (2000 μl;
corresponding to ~1000 μl of resin) was prepared as described in Materials and
methods. The virus was concentrated into 7 ml using amicon columns and incubated
with the resin with shaking for 1 h at RT. The virus/resin mixture was added to an
empty PD10 column and allowed to set. The rest of the procedure was performed as
described in Materials and methods. (A) The fractions were HCV infectivity titrated in
an FFU assay, shown as mean of three replicates with SD (lower cut-off: 500 FFUs/ml).
Star, titer below cut-off. (B) Total FFUs in fractions was calculated by multiplying
fraction titers with volumes. The % of FFUs compared to the input was calculated by
normalizing to the amount of FFUs in the input fractions (pre-column).particular protein was the most abundant in the puriﬁed fractions; it
was present at around 25 pg/μl. This ﬁnding suggested that the ratio
between FFUs and total protein was probably increased signiﬁcantly
more than 1200-fold by the puriﬁcation.
Finally,we tested virion stability following puriﬁcation by subjecting
puriﬁed andnon-puriﬁed virions to one to four freeze/thaw(F/T) cycles.
As we had indications that stability in fact might be decreased by
puriﬁcation, we included a test of 10% iodixanol as an additive to
possibly increase stability of puriﬁed virus.Weobservednoeffect of four
consecutive F/T cycles for the non-puriﬁed ﬂag-tagged virus, whereas
about half the infectivity was lost for each F/T cycle of the puriﬁed virus
(Fig. 9). However, virus resilience to consecutive F/T cycles was
Table 1
Infectivity titration and protein concentration measurements revealed a four-fold increase in speciﬁc infectivity and a highly signiﬁcant increase in the FFU to protein ratio following
afﬁnity chromatography puriﬁcation of J6/JFH1ﬂag. Pre-column fraction and elution fraction 1 of the M1 resin puriﬁcation from Fig. 7 were infectivity titrated by FFU assay, HCV RNA
titrated by qPCR and the protein concentration was determined by a sensitive Bradford protein determination assay (cut-off: 8 μg/ml); procedures were as described inMaterials and
methods.
Infectivity titera (FFUs/ml)log10 HCV RNA titer (IU/ml)log10 Protein content (μg/ml) FFUs/IU FFUs/μg protein
Pre-column 4.6 7.9 9800 5.0×10−4 4.1
Elution fraction 1 4.6 7.3 b8 2.0×10−3 N5000
a The infectivity titers were the same for the 6.7 ml pre-column fraction as for the 1.8 ml elution fraction 1.
153Rapid Communicationcompletely restored by the addition of 10% iodixanol (Fig. 9), thereby
suggesting that this additive was ideal for the preservation of virus
infectivity during cryo-storage.
Discussion
In the present study, we demonstrated that the HCV recombinant
J6/JFH1 could be ﬂag-tagged at the very N-terminus of E2 apparently
without inﬂuencing infection in Huh7.5 cells. This is in difference to a
recent report in which ﬂag insertion close to the N-terminus of E2,
replacing part of HVR1, severely attenuated infectivity of a closely
related HCV recombinant (Takahashi et al., 2010). Takahashi et al.
(2010) reported rescue of infectivity of ﬂag-tagged HCV by an
envelope mutation, but density analysis revealed that the physio-
chemical properties of the adapted virus were still signiﬁcantly
altered. In contrast, we did not observe a need for adaptation of J6/
JFH1 upon insertion of ﬂag tag with a short linker at the N-terminus of
E2, nor did we observe signiﬁcant changes in the physiochemical
properties of the ﬂag-tagged virus. Infectious HCV particles and HCV
RNA for both J6/JFH1 and J6/JFH1ﬂag were found in density fractions
between ~1.01–1.10 and ~1.0–1.12 g/ml, respectively. This closely
approximates reports by others for HCV derived from patients (Andre
et al., 2002), experimentally infected chimpanzees (Lindenbach et al.,
2006) and from cell culture (Grove et al., 2008). This is of major
importance, as the interpretation of results obtained using these
tagged viruses will depend greatly on the assumption that the nature
of the HCV life cycle and virion structure are maintained.
Our observations that the ﬂag tag allowed for highly efﬁcient and
speciﬁc immuno-staining of infected cells suggest that J6/JFH1ﬂag will
prove a very valuable tool in confocal imaging and co-localizationFig. 8. Silver staining of fractions from afﬁnity puriﬁcation of J6/JFH1ﬂag viruses revealed efﬁc
were loaded for SDS-PAGE and the gel was subsequently subjected to silver staining using th
above: PC (pre-column), FT (ﬂow-through), W1 (wash 1), W2 (wash 2), E1–E5 (elution 1 to
protein determination. Total volume from fraction and the corresponding protein content istudies using the ﬂag antibody, especially since it would appear that
HCV E2 function was not greatly inﬂuenced by the ﬂag insertion. Also,
it should be possible to utilize the E2 N-terminal ﬂag tag for
visualization of E2 from highly divergent HCV genotype isolates, for
which envelope-speciﬁc antibodies are not available. It is interesting
that we observed ~90% neutralization of ﬂag-tagged virus using
antibodies against the ﬂag peptide. Since the ﬂag tag should not have
any speciﬁc role in the HCV entry process, this observation provides
evidence in support of the hypothesis that neutralization can occur by
steric hindrance of protein motifs other than the one the antibody is
actually binding to.
Using afﬁnity-based column chromatographywewere able to purify
ﬂag-tagged infectious HCV particles from protein contaminants of the
medium by over a 1000-fold as measured by protein determinations of
puriﬁcation fractions. In fact, we were unable to detect protein in the
elution fractions, and silver staining revealed that the purity was
probably even higher. Comparing the two main resins used in
puriﬁcation of ﬂag-tagged recombinant proteins, we found the M1
resin to be superior to another resin M2 because of the inexpensive
eluting agent (EDTA) aswell as the slightly higher recovery of infectious
particles. Using resin M1 we were able to elute ~30% of input of
infectious particles in two separate column puriﬁcations.We attempted
to boost recovery by incubating the resin with the virus for 1 h at RT
prior to washing, but although we did observe increased binding we
were still not able to elute more than 30% of infectious virus input.
Finally, we found that puriﬁed virions were unstable when subjected to
freeze/thaw cycles in contrast to non-puriﬁed virions. As we were able
to completely restore freeze/thaw stability by the addition of 10%
iodixanol it would appear that this decreased stability of puriﬁed virions
was related to the buffering effect of the protein content of full mediumient removal of proteins by resin M1. Fractions from puriﬁcation using M1 resin (Fig. 7)
e SilverXpress kit (Invitrogen). All fractions shown in Fig. 7 were loaded and are shown
5). No more than 1 μg of protein was loaded for each sample as measured by Bradford
s shown.
Fig. 9. Puriﬁed J6/JFH1ﬂag, but not puriﬁed J6/JFH1ﬂag with 10% iodixanol was sensitive to
repeated freeze/thaw (F/T) cycles. Non-puriﬁed J6/JFH1ﬂag, puriﬁed J6/JFH1ﬂag and
puriﬁed J6/JFH1ﬂag with 10% iodixanol were subjected to one to four F/T cycles prior to
infectivity titration by FFU assay, together with a control that was stored at 4 °C (Not
frozen)while freeze/thaw cyclingwas performed. Infectivity titerswere normalized to the
respective control sample, and are indicated as % of this infectivity titer, shown with SD.
154 Rapid Communicationas is known to be the case for the cryo-storage of other biological
reagents, such as antibodies. In any case, addition of 10% iodixanol
restored stability of puriﬁed virions, and would appear to be an ideal
choice for the storage of puriﬁed infectious HCV due to its low reactivity
and isoosmotic nature.
In conclusion, we have discovered what would appear to be the
ideal placement of a ﬂag tag into the structural genes of HCV. The tag
had very little, if any, effect on the viral life cycle and allows for
efﬁcient immuno-staining of ﬂag-E2 protein in infected Huh7.5 cells.
In addition, it was possible to generate a pure preparation of virus
particles with an effective recovery of about 30%, and store these
particles with no signiﬁcant loss in HCV infectivity by the addition of
10% iodixanol. The ﬂag-tagged virus is therefore an excellent tool for
probing HCV E2 functions, for virion puriﬁcation and composition
analysis, as well as possibly for the development of an inactivated
whole-virus virus vaccine.
Materials and methods
Plasmids
A plasmid encoding full-length HCV genotype 2a, J6/JFH1, was
used (Lindenbach et al., 2005). The Core-NS2 genes were of the isolate
J6CF (Yanagi et al., 1999) and the NS3-NS5B genes and UTRs were of
the isolate JFH1 (Wakita et al., 2005). The constructs with EGFP or ﬂag
tag insertions at the N-terminus of HCV protein E2 were generated by
using conventional cloning techniques. In the case of the ﬂag-tagged
construct a nucleotide sequence (GATTATAAGGATGATGATGA
TAAGCTGCCGGGCACGGGC) encoding 13 amino acids (ﬂag tag and
linker) was inserted at the N-terminus of E2 (starting from nucleotide
position 1490 of pJ6/JFH1). A maxiprep was prepared of both
constructs and the entire HCV sequence with insert was conﬁrmed.
Cells and cell culture
Huh7.5 cells were cultured in DMEM supplemented with 10% fetal
calf serum at 37 °C and 5% CO2. Cells were passaged every 2–3 days.
Transfections were carried out as described (Scheel et al., 2008) by
restriction-enzyme digestion of HCV plasmids with XbaI, mung bean
treatment of DNA and ﬁnally in vitro transcription to generate full-
length HCV RNA transcripts. These were then transfected into Huh7.5cells using Lipofectamine2000 (Invitrogen). In all transfections a J6/
JFH1GND control virus was included (which is unable to replicate and
spread due to the GND mutation motif in NS5B) and we observed no
HCV positive cells in these transfections. For transfections and
infections, the percentage of viral spread in culture was assessed by
plating cells onto slides at each day of passage and HCV NS5A-speciﬁc
immuno-staining of the slide the following day as previously
described (Gottwein et al., 2007). Cell culture supernatants were
ﬁltered (0.45 μm, Nalgene) and stored at −80 °C.
Determination of cell culture supernatant HCV infectious titers
Huh7.5 cells/well (6×103) were plated into poly-D-lysine-coated
96-well plates (Nunc) the day before the infectious titer assay.
Infection was performed using ten-fold dilution series of virus
supernatants in three independent virus dilutions and was carried
out as previously described (Gottwein et al., 2007). FFU counting was
mostly done using an automated ImmunoSpot Series 5 UV Analyzer
(Gottwein et al., 2010). Here, background was deﬁned as the mean
FFU count of at least six replicates without virus and subtracted
from assay values (mean never exceeded 15 FFUs/well). Lower cut-off
was set at 3+background+3×standard deviation of background,
and upper cut-off at 200 FFUs/well, based on the linear range of a
test dilution series. The effect of using undiluted samples in deter-
mining infectious titers was tested by including a minimum dilution
of 1:2. In some cases where the number of FFUs was relatively low
manual FFU counting was done instead. Wells counted had at least
5 FFUs/well.
Determinations of HCV RNA titers
Supernatant HCV RNA titers weremeasured by an in house reverse
transcription qPCR, modiﬁed from Gottwein et al. (2007), by the
inclusion of an internal HCV (J6/JFH1) titer stock used as a control of
cross-assay variation as well as an in-house HCV (J6/JFH1) dilution
series included to establish the standard curve.
Sequence analysis
HCV RNA extraction from culture supernatants of J6/JFH1 viruses
with and without ﬂag tag insertion and subsequent ORF sequencing
was performed by long RT-nested PCR procedures, as previously
described (Gottwein et al., 2007).
Equilibrium density gradient centrifugation
Step-gradients were made by layering 2.5 ml each of 40%, 30%, 20%
and 10% Optiprep™ (iodixanol, Axis-Shield) onto each other. The four
iodixanol solutions were prepared by dilution with PBS from the 60%
stock. The step-gradients were left upright 24 h at 4 °C for formation of
semi-continuous gradients. Samples were loaded directly on top of the
gradients and spun at 35,000 RPM (~151,000×RCF) for 16 h at 4 °C
using a Beckman SW-41 rotor mounted in a Beckman XL-70 ultracen-
trifuge. After centrifugation, ~700 μl gradient fractions were harvested
from the bottomand 500 μl wereweighed (SI-114, Denver Instruments)
to calculate fraction densities. Fractions were titrated for HCV infectivity
at 1:50 and 1:500 dilutions and HCV RNA was titrated at 1:10 dilutions.
Flag-speciﬁc immuno-staining of infected cells
Naive Huh7.5 cells and cultures infected with J6/JFH1 and J6/
JFH1ﬂag, respectively, were plated onto slides. The following day the
cells were ﬁxed using 0.5% PFA for 15 min in PBS with 0.1% Triton-X
100. Following ﬁxation the cells were incubated with 1% BSA and 0.2%
skim milk in PBS for 20 min at RT. The cells were then incubated
with primary antibodies using rabbit polyclonal anti-ﬂag antibody at
155Rapid Communication1.25 μg/ml (F7425, Sigma) together with mouse monoclonal HCV
anti-NS5A antibody (clone 9E10) at 0.1 μg/ml. The slides were
incubated with primary antibodies in PBS with 0.1% Tween 20 ON at
4 °C. They were then washed and incubated for 10 min with
secondary antibodies in PBS with 0.1% Tween 20. Secondary staining
of cells was performed using anti-mouse alexa594 conjugated
antibody (A11005, Invitrogen) and anti-rabbit alexa488 conjugated
antibody (A21441, Invitrogen), both at 4.0 μg/ml. Nuclei were
counterstained using Hoechst at ~1 μg/ml. Images are averages of 10
acquisitions andwere acquired sequentially using a Leica SP2 confocal
microscope with a diode laser, an argon laser and a HeNe laser and
with a 20× HC PL APO objective (NA 0.7).
Virus neutralization by ﬂag-speciﬁc antibody
Huh7.5 cells/well (6×103) were plated into poly-D-lysine-coated
96-well plates (Nunc) the day before the neutralization assay. The
following day ~100 FFUs of HCV was incubated 1 h at 37 °C with ten-
fold dilutions of anti-ﬂag monoclonal antibody M2 (Sigma) and
subsequently incubated with cells for 3 h. Forty-eight hours after
infection the cells were immuno-stained for HCV NS5A (Gottwein et al.,
2010; Scheel et al., 2008). Neutralizationwas done in four replicates and
normalized to a six replicates of virus only.
Puriﬁcation of virus particles by afﬁnity chromatography
Agarose resin conjugated to either anti-ﬂag antibody M1 (A4596,
Sigma) or M2 (A2220, Sigma) was used for virus puriﬁcation. Virus
was concentrated prior to puriﬁcation by centrifugation in ﬁlter
columns (Amicon, molecular weight cut-off: 100,000 kDa) to reduce
the volume loaded onto the resin. Resins were transferred to empty
PD10 columns and allowed to set. Five gel volumes of solution A
(0.1 M glycine, pH 3.5) was passed through the column to remove any
contaminants blocking the binding sites. The following applies to the
use of resin M1: The gel was equilibrated using ten gel volumes of
solution B (0.05 M Tris, 0.15 M NaCl, 10 mM CaCl2, pH 7.4). A 1:10
dilution of solution C (0.5 M Tris, 1.5 M NaCl, 100 mM CaCl2, pH 7.4))
was added to the concentrated virus and it was passed through the gel
two times, unless otherwise stated. The gel was washed twice with 10
gel volumes of solution B. Mild elution was then carried out by three
1.8 ml volumes of solution D (0.05 M Tris, 0.15 M NaCl, 5 mM EDTA,
pH 7.4) and subsequently two to three 1.8 ml volumes of solution A
was used for acidic elution into 35 μl of solution E (1 M Tris pH 8.0) for
the purpose of achieving a neutral pH. The following applies to the use
of resin M2: The gel was equilibrated using 10 gel volumes of PBS. The
concentrated virus was passed through the gel two times. The gel was
washed twice with 10 gel volumes of PBS. Mild elution was then
carried out by three 1.8 ml volumes of PBS containing 150 μg/ml of
3×ﬂag peptide (F4799, Sigma) and subsequently two to three 1.8 ml
volumes of solution A was used for acidic elution into 35 μl of solution
E for the purpose of achieving a neutral pH.
Bradford protein determinations
Protein measurements were performed as per the manufacturer's
instructions using Bradford reagent (Sigma) with a veriﬁed sensitivity
of 8 ng protein per μl.
SDS-PAGE and silver staining
Samples were incubated with SDS loading buffer under reducing
conditions at 70 °C for 10 min prior to loading into wells of NuPAGENovex 10% Bis–Tris gels (Invitrogen) and run in an XCell II SureLock
Mini-Cell (Invitrogen). Using a two-fold dilution series of a protein of
known concentration the SilverXpress silver staining kit (Invitrogen)
was veriﬁed to have a sensitivity of ~1 ng/ protein band. The kit was
used as per the manufacturer's instructions.Acknowledgments
We are grateful to Anna-Louise Sørensen and LotteMikkelsen (CO-
HEP) for technical assistance; to Jens Ole Nielsen, Ove Andersen and
Kristian Schønning (Copenhagen University Hospital, Hvidovre) for
their support of the project and to Charles Rice (Rockefeller
University) for providing reagents.
This study was supported by a Ph.D. stipend from Faculty of Health
Sciences, University of Copenhagen (JP), and by research grants from
the Lundbeck Foundation (JB), the Danish Cancer Society (JB) and
from the Novo Nordisk Foundation (JB).References
Alter, H.J., Seeff, L.B., 2000. Recovery, persistence, and sequelae in hepatitis C virus
infection: a perspective on long-term outcome. Semin. Liver Dis. 20, 17–35.
Andre, P., Komurian-Pradel, F., Deforges, S., Perret, M., Berland, J.L., Sodoyer, M., Pol, S.,
Brechot, C., Paranhos-Baccala, G., Lotteau, V., 2002. Characterization of low- and
very-low-density hepatitis C virus RNA-containing particles. J. Virol. 76,
6919–6928.
Gottwein, J.M., Bukh, J., 2008. Cutting the gordian knot-development and biological
relevance of hepatitis C virus cell culture systems. Adv. Virus Res. 71, 51–133.
Gottwein, J.M., Scheel, T.K., Hoegh, A.M., Lademann, J.B., Eugen-Olsen, J., Lisby, G., Bukh,
J., 2007. Robust hepatitis C genotype 3a cell culture releasing adapted inter-
genotypic 3a/2a (S52/JFH1) viruses. Gastroenterology 133, 1614–1626.
Gottwein, J.M., Scheel, T.K., Jensen, T.B., Lademann, J.B., Prentoe, J.C., Knudsen, M.L.,
Hoegh, A.M., Bukh, J., 2009. Development and characterization of hepatitis C virus
genotype 1–7 cell culture systems: role of CD81 and scavenger receptor class B type
I and effect of antiviral drugs. Hepatology 49, 364–377.
Gottwein, J.M., Scheel, T.K., Callendret, B., Li, Y.P., Eccleston, H.B., Engle, R.E.,
Govindarajan, S., Satterﬁeld, W., Purcell, R.H., Walker, C.M., Bukh, J., 2010. Novel
infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain
ED43): genetic analyses and in vivo pathogenesis studies. J. Virol. 84, 5277–5293.
Grove, J., Nielsen, S., Zhong, J., Bassendine, M.F., Drummer, H.E., Balfe, P., McKeating, J.A.,
2008. Identiﬁcation of a residue in hepatitis C virus E2 glycoprotein that determines
scavenger receptor BI and CD81 receptor dependency and sensitivity to
neutralizing antibodies. J. Virol. 82, 12020–12029.
Lindenbach, B.D., Evans, M.J., Syder, A.J., Wolk, B., Tellinghuisen, T.L., Liu, C.C.,
Maruyama, T., Hynes, R.O., Burton, D.R., McKeating, J.A., Rice, C.M., 2005. Complete
replication of hepatitis C virus in cell culture. Science 309, 623–626.
Lindenbach, B.D., Meuleman, P., Ploss, A., Vanwolleghem, T., Syder, A.J., McKeating, J.A.,
Lanford, R.E., Feinstone, S.M., Major, M.E., Leroux-Roels, G., Rice, C.M., 2006. Cell
culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro.
Proc. Natl. Acad. Sci. USA 103, 3805–3809.
Nielsen, S.U., Bassendine, M.F., Burt, A.D., Martin, C., Pumeechockchai, W., Toms, G.L.,
2006. Association between hepatitis C virus and very-low-density lipoprotein
(VLDL)/LDL analyzed in iodixanol density gradients. J. Virol. 80, 2418–2428.
Scheel, T.K., Gottwein, J.M., Jensen, T.B., Prentoe, J.C., Hoegh, A.M., Alter, H.J., Eugen-
Olsen, J., Bukh, J., 2008. Development of JFH1-based cell culture systems for
hepatitis C virus genotype 4a and evidence for cross-genotype neutralization. Proc.
Natl. Acad. Sci. USA 105, 997–1002.
Syed, G.H., Amako, Y., Siddiqui, A., 2010. Hepatitis C virus hijacks host lipid metabolism.
Trends Endocrinol. Metab. 21, 33–40.
Takahashi, H., Akazawa, D., Kato, T., Date, T., Shirakura, M., Nakamura, N., Mochizuki, H.,
Tanaka-Kaneko, K., Sata, T., Tanaka, Y., Mizokami, M., Suzuki, T., Wakita, T., 2010.
Biological properties of puriﬁed recombinant HCV particles with an epitope-tagged
envelope. Biochem. Biophys. Res. Commun. 395, 565–571.
Thomssen, R., Bonk, S., Propfe, C., Heermann, K.H., Kochel, H.G., Uy, A., 1992. Association
of hepatitis C virus in human sera with beta-lipoprotein. Med. Microbiol. Immunol.
181, 293–300.
Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K.,
Habermann, A., Krausslich, H.G., Mizokami, M., Bartenschlager, R., Liang, T.J., 2005.
Production of infectious hepatitis C virus in tissue culture from a cloned viral
genome. Nat. Med. 11, 791–796.
Yanagi, M., Purcell, R.H., Emerson, S.U., Bukh, J., 1999. Hepatitis C virus: an infectious
molecular clone of a second major genotype (2a) and lack of viability of intertypic
1a and 2a chimeras. Virology 262, 250–263.
